specialty pharmaceuticals

Catalyst Pharmaceuticals trades at 20-33% discount to peers with 7.5% FCF yield; 2026 Hetero litigation is binary catalyst determining if shares reach $28-32 or collapse to $16-20.

Tilray expands UK pharmaceutical distribution via CC Pharma's partnership with Smartway Pharmaceuticals, combining distribution networks and manufacturing expertise to serve the £1 billion market.